Virology Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut De Recherche En Santé, Environnement Et Travail) - UMR_S 1085, F-35000 Rennes, France.
Maladies Infectieuses Et Réanimation Médicale, CHU Rennes, Inserm-CIC 1414, Biosit, F-35043 Rennes, France.
J Clin Virol. 2021 Mar;136:104761. doi: 10.1016/j.jcv.2021.104761. Epub 2021 Feb 12.
The link between influenza virus (IV) viral load (VL) in respiratory samples and disease severity is not clearly established. This study was designed to assess IV-VL in respiratory samples from flu patients admitted to intensive care unit (ICU).
Patients admitted to ICU for IV infection, as documented by RT-PCR, with respiratory failure were included in the study during 5 flu-seasons (2014-2018). Routine ICU management parameters were recorded. Real-time amplification Ct-values for IV and cell GAPDH gene were measured in each respiratory sample collected at ICU admission.
Among 105 included patients, 59 (56.1%) presented an acute respiratory distress syndrome (ARDS). The overall mortality was 21%. IV-load assessed by amplification Ct-values and virus-over-cell ratio (expressed as log) in each respiratory sample ranged from 20 to 40 and -5.2-3.7, respectively, and did not differ according to the type of sample and IV-A or -B type. Cell richness was higher in samples from ARDS patients compared to non-ARDS (p = 0.0003) but no difference was noted for IV Ct-values. In ARDS-patients, IV Ct-values (p = 0.020) and the virus-per-cell ratio (p = 0.038) were significantly higher in sample from patients who eventually died compared to those who survived. These 2 parameters remain independently associated with mortality with an odd-ratio of 1.21 and 2.19, respectively (p < 0.05).
While IV-VL does not seem to predict disease evolution in ICU flu-patients, normalized measurement of IV-VL in respiratory samples could be useful in ARDS patients to identify patients at higher risk of mortality.
流感病毒(IV)在呼吸道样本中的病毒载量(VL)与疾病严重程度之间的联系尚不清楚。本研究旨在评估重症监护病房(ICU)收治的流感患者的呼吸道样本中的 IV-VL。
在 5 个流感季节(2014-2018 年)期间,将经 RT-PCR 确诊为 IV 感染且呼吸衰竭而入住 ICU 的患者纳入本研究。记录常规 ICU 管理参数。在 ICU 入院时采集的每个呼吸道样本中测量 IV 和细胞 GAPDH 基因的实时扩增 Ct 值。
在 105 例纳入患者中,有 59 例(56.1%)发生急性呼吸窘迫综合征(ARDS)。总体死亡率为 21%。每个呼吸道样本的扩增 Ct 值评估的 IV 载量和病毒与细胞的比值(以对数表示)分别为 20 到 40 和-5.2 到 3.7,且与样本类型和 IV-A 或 -B 类型无关。ARDS 患者的样本细胞丰富度高于非 ARDS 患者(p=0.0003),但 IV Ct 值无差异。在 ARDS 患者中,最终死亡患者的 IV Ct 值(p=0.020)和病毒与细胞的比值(p=0.038)均显著高于存活患者。这两个参数与死亡率独立相关,优势比分别为 1.21 和 2.19(p<0.05)。
虽然 IV-VL 似乎不能预测 ICU 流感患者的疾病进展,但在 ARDS 患者中对呼吸道样本中 IV-VL 进行归一化测量可能有助于识别死亡率较高的患者。